As multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.
Just as cancer takes many forms, so does genetic testing. Here’s what you need to know.
WalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.
Biosimilars in the United States are slowly gaining traction, but widespread confusion and legal barriers remain.
Why today’s models will always be interim ones—and
how the consumerization of healthcare will drive change.
In an era when adherence to specialty pharmaceuticals is disturbingly low, value-based pricing needs real-world results, not single-arm accelerated trials.
The Supreme Court recently held that the North Carolina Dental Board was not insulated from federal antitrust liability under the so-called “state action” doctrine when it engaged in anticompetitive conduct to restrain non-dentists from performing teeth whitening services.